Repository logo
 
Publication

Genetic alterations of ALK in high-risk neuroblastoma patients: a SIOPEN study

2018-10-10Conference object Open access
Simple item page
dc.contributor.authorBellini, Angela
dc.contributor.authorBernard, Virginie
dc.contributor.authorAmbros, Inge
dc.contributor.authorAmbros, Peter F.
dc.contributor.authorde Preter, Katleen
dc.contributor.authorCombaret, Valérie
dc.contributor.authorBeiske, Klaus
dc.contributor.authorJeison, Marta
dc.contributor.authorMarques, Barbara
dc.contributor.authorMorini, Martina
dc.contributor.authorMazzocco, Katia
dc.contributor.authorDefferrari, Raffaella
dc.contributor.authorBetts, David
dc.contributor.authorMartinsson, Tommy
dc.contributor.authorMühlethaler-Mottet, Annick
dc.contributor.authorNoguera, Rosa
dc.contributor.authorFont de Mora, Jaime
dc.contributor.authorVicha, Ales
dc.contributor.authorLadenstein, Ruth
dc.contributor.authorValteau-Couanet, Dominique
dc.contributor.authorRossing, Caroline Maria
dc.contributor.authorBown, Nick
dc.contributor.authorTweddle, Deborah
dc.contributor.authorAvigad, Smadar
dc.contributor.authorLapouble, Eve
dc.contributor.authorChicard, Mathieu
dc.contributor.authorLeprovost, Nada
dc.contributor.authorClement, Nathalie
dc.contributor.authorBaulande, Sylvain
dc.contributor.authorPierron, Gaelle
dc.contributor.authorIrene, Jimenez
dc.contributor.authorJaydutt, Bhalshankar
dc.contributor.authorDelattre, Olivier
dc.contributor.authorMichon, Jean
dc.contributor.authorSchleiermacher, Gudrun
dc.date.accessioned2019-02-19T16:30:46Z
dc.date.available2019-02-19T16:30:46Z
dc.date.issued2018-10-10
dc.description.abstractBackground: In neuroblastoma (NB), the ALK receptor tyrosine kinase can be constitutively activated either through genomic amplification or activating point mutations. We studied ALK genetic alterations in high-risk NB patients to determine their frequency and prognostic impact.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/5900
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectNeuroblastomapt_PT
dc.subjectALKpt_PT
dc.subjectTumor Genomicspt_PT
dc.subjectDoenças Genéticaspt_PT
dc.titleGenetic alterations of ALK in high-risk neuroblastoma patients: a SIOPEN studypt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceJerusalém, Israelpt_PT
oaire.citation.titleSIOPEN – International Collaboration for Neuroblastoma Research, Annual General Meeting 2018 - 30-year anniversary Conference, 10 Oct 2018pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Abstract ALK SIOPEN SIOPEM Oct2018_submittedVers.pdf
Size:
266.82 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DGH - Posters/abstracts em congressos internacionais